Literature DB >> 25174406

Suppression of scinderin modulates epithelial‑mesenchymal transition markers in highly metastatic gastric cancer cell line SGC‑7901.

Xiao-Min Chen1, Jun-Ming Guo1, Ping Chen2, Lian-Gang Mao2, Wei-Yun Feng2, Dong-Hai Le2, Ke-Qiang Li1.   

Abstract

Scinderin is a Ca2+‑dependent filamentous actin (F‑actin) severing and capping protein, which has a key role in regulated secretion. However, little is known regarding the function and mechanism of scinderin in human carcinoma development and progression. In the present study, the biological function of scinderin was investigated using a cell proliferation assay, flow cytometric analysis and a Transwell assay in highly tumorigenic and the metastatic human gastric cancer cell line SGC‑7901 transfected with scinderin‑small hairpin RNA lentivirus. The changes in the expression of epithelial‑mesenchymal transition (EMT) markers were also investigated. The results indicated that scinderin knockdown effectively suppressed proliferation, reduced migration and arrested the cell cycle of the SGC‑7901 cells at G2/M phase. Furthermore, scinderin knockdown altered the expression of EMT markers; the expression of E‑cadherin was significantly upregulated, along with an evident decrease in N‑cadherin and β‑catenin expression. In conclusion, the present study suggested that suppression of scinderin impaired proliferation and migration of gastric cancer SGC‑7901 cells and attenuates its EMT process. Scinderin may therefore be a potential target for tumor EMT and therapy against gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25174406     DOI: 10.3892/mmr.2014.2523

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  8 in total

1.  Scinderin-knockdown inhibits proliferation and promotes apoptosis in human breast carcinoma cells.

Authors:  Wenjing Jian; Xiaoli Zhang; Jiguo Wang; Yunlong Liu; Chuting Hu; Xianming Wang; Renbin Liu
Journal:  Oncol Lett       Date:  2018-06-21       Impact factor: 2.967

2.  Scinderin is a novel transcriptional target of BRMS1 involved in regulation of hepatocellular carcinoma cell apoptosis.

Authors:  Xiaojing Qiao; Yiren Zhou; Wenjuan Xie; Yi Wang; Yicheng Zhang; Tian Tian; Jianming Dou; Xi Yang; Suqin Shen; Jianwei Hu; Shouyi Qiao; Yanhua Wu
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

3.  Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma.

Authors:  Bin Zhou; Tian-Wei Chen; Ya-Bo Jiang; Xu-Biao Wei; Chong-De Lu; Jing-Jing Li; Dong Xie; Shu-Qun Cheng
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

4.  Scinderin promotes the invasion and metastasis of gastric cancer cells and predicts the outcome of patients.

Authors:  Jia-Jia Liu; Jun-Yan Liu; Jun Chen; Yi-Xi Wu; Peng Yan; Cheng-Dong Ji; Yan-Xia Wang; Dong-Fang Xiang; Xia Zhang; Peng Zhang; You-Hong Cui; Ji Ming Wang; Xiu-Wu Bian; Feng Qian
Journal:  Cancer Lett       Date:  2016-03-24       Impact factor: 8.679

5.  Transcriptome profiling reveals PDZ binding kinase as a novel biomarker in peritumoral brain zone of glioblastoma.

Authors:  Banavathy S Kruthika; Ruchi Jain; A Arivazhagan; R D Bharath; T C Yasha; Paturu Kondaiah; Vani Santosh
Journal:  J Neurooncol       Date:  2018-11-20       Impact factor: 4.130

6.  Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioning.

Authors:  Jaeseung Song; Daeun Kim; Sora Lee; Junghyun Jung; Jong Wha J Joo; Wonhee Jang
Journal:  Commun Biol       Date:  2022-06-22

7.  Calcium-controlled conformational choreography in the N-terminal half of adseverin.

Authors:  Sakesit Chumnarnsilpa; Robert C Robinson; Jonathan M Grimes; Cedric Leyrat
Journal:  Nat Commun       Date:  2015-09-14       Impact factor: 14.919

8.  Loss of scinderin decreased expression of epidermal growth factor receptor and promoted apoptosis of castration-resistant prostate cancer cells.

Authors:  Xiaofeng Lai; Weipeng Su; Hu Zhao; Shunliang Yang; Tengyue Zeng; Weizhen Wu; Dong Wang
Journal:  FEBS Open Bio       Date:  2018-04-10       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.